Bioharvest Sciences (BHST) Cost of Revenue (2023 - 2025)

Bioharvest Sciences' Cost of Revenue history runs 3 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• In Q4 2025, Cost of Revenue fell 23.74% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $14.0 million (up 19.59% YoY), while the FY2025 annual figure was $14.0 million, up 19.59% from the prior year.
• Cost of Revenue was $2.2 million for Q4 2025 at Bioharvest Sciences, down from $4.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $4.1 million in Q3 2025 to a low of $1.6 million in Q2 2023.
• Historically, Cost of Revenue has averaged $2.9 million across 3 years, with a median of $2.9 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue soared 90.15% in 2024, then dropped 23.74% in 2025.
• A 3-year view of Cost of Revenue shows it stood at $2.9 million in 2023, then grew by 0.14% to $2.9 million in 2024, then decreased by 23.74% to $2.2 million in 2025.
• The last three Cost of Revenue figures came in at $2.2 million (Q4 2025), $4.1 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.